WallStreetZenWallStreetZen

NASDAQ: SEEL
Seelos Therapeutics Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for SEEL

Based on 1 analyst offering 12 month price targets for Seelos Therapeutics Inc.
Min Forecast
$4.00+247.83%
Avg Forecast
$4.00+247.83%
Max Forecast
$4.00+247.83%

Should I buy or sell SEEL stock?

Based on 1 analyst offering ratings for Seelos Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SEEL stock forecasts and price targets.

SEEL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
B. Riley Securities
Top 1%
100
Strong BuyMaintains$4.00+247.83%2022-03-14

1 of 1

Forecast return on equity

Is SEEL forecast to generate an efficient return?
Company
N/A
Industry
15.35%
Market
62.84%

Forecast return on assets

Is SEEL forecast to generate an efficient return on assets?
Company
N/A
Industry
13.55%

SEEL earnings per share forecast

What is SEEL's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$0.82
Avg 2 year Forecast
-$0.75
Avg 3 year Forecast
-$0.99

SEEL revenue forecast

What is SEEL's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$11.0M
Avg 2 year Forecast
$125.5M
Avg 3 year Forecast
$288.4M

SEEL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SEEL$1.15$4.00+247.83%Strong Buy
MTNB$0.57N/AN/A
CDXC$1.66$4.97+199.22%Buy
KALV$5.09$25.50+400.98%Strong Buy
MREO$0.82$4.33+425.85%Strong Buy

Seelos Therapeutics Stock Forecast FAQ

Is Seelos Therapeutics Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SEEL) stock is to Strong Buy SEEL stock.

Out of 1 analyst, 1 (100%) are recommending SEEL as a Strong Buy, 0 (0%) are recommending SEEL as a Buy, 0 (0%) are recommending SEEL as a Hold, 0 (0%) are recommending SEEL as a Sell, and 0 (0%) are recommending SEEL as a Strong Sell.

If you're new to stock investing, here's how to buy Seelos Therapeutics stock.

What is SEEL's earnings growth forecast for 2022-2024?

(NASDAQ: SEEL) Seelos Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Seelos Therapeutics's earnings in 2022 is -$82,136,000.On average, 2 Wall Street analysts forecast SEEL's earnings for 2022 to be -$87,877,970, with the lowest SEEL earnings forecast at -$125,386,860, and the highest SEEL earnings forecast at -$51,440,763. On average, 2 Wall Street analysts forecast SEEL's earnings for 2023 to be -$80,376,192, with the lowest SEEL earnings forecast at -$110,383,304, and the highest SEEL earnings forecast at -$51,440,763.

In 2024, SEEL is forecast to generate -$106,096,573 in earnings, with the lowest earnings forecast at -$106,096,573 and the highest earnings forecast at -$106,096,573.

What is SEEL's revenue growth forecast for 2022-2024?

(NASDAQ: SEEL) Seelos Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 24.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.69%.

Seelos Therapeutics's revenue in 2022 is $0.On average, 1 Wall Street analysts forecast SEEL's revenue for 2022 to be $1,177,779,133, with the lowest SEEL revenue forecast at $1,177,779,133, and the highest SEEL revenue forecast at $1,177,779,133. On average, 1 Wall Street analysts forecast SEEL's revenue for 2023 to be $13,447,472,763, with the lowest SEEL revenue forecast at $13,447,472,763, and the highest SEEL revenue forecast at $13,447,472,763.

In 2024, SEEL is forecast to generate $30,905,181,665 in revenue, with the lowest revenue forecast at $30,905,181,665 and the highest revenue forecast at $30,905,181,665.

What is SEEL's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: SEEL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 13.55%.

What is SEEL's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SEEL price target, the average SEEL price target is $4.00, with the highest SEEL stock price forecast at $4.00 and the lowest SEEL stock price forecast at $4.00.

The Wall Street analyst predicted that Seelos Therapeutics's share price could reach $4.00 by Mar 14, 2023. The average Seelos Therapeutics stock price prediction forecasts a potential upside of 247.83% from the current SEEL share price of $1.15.

What is SEEL's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: SEEL) Seelos Therapeutics's current Earnings Per Share (EPS) is -$0.79. On average, analysts forecast that SEEL's EPS will be -$0.82 for 2022, with the lowest EPS forecast at -$1.17, and the highest EPS forecast at -$0.48. On average, analysts forecast that SEEL's EPS will be -$0.75 for 2023, with the lowest EPS forecast at -$1.03, and the highest EPS forecast at -$0.48. In 2024, SEEL's EPS is forecast to hit -$0.99 (min: -$0.99, max: -$0.99).

What is SEEL's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: SEEL) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.